Pfizer tests two pill versions in healthy volunteers
NCT ID NCT07117799
First seen Jan 06, 2026 · Last updated May 07, 2026 · Updated 20 times
Summary
This completed Phase 1 study by Pfizer involved 24 healthy adults to compare how the body absorbs two different pill forms of an experimental drug called PF-07248144. Participants received a single dose of each form in a crossover design, and researchers measured drug levels in the blood. The goal was to see if the two forms work similarly, which helps decide which version to use in future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.